RxDoctor Payments Data

Jessica Holman, NP

Family · Bismarck, NDNPI 1720658743

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,283 of the $3,533 with a category attached, or 64.6%. 13 manufacturers reported payments, led by Kerecis Limited at 41.7% of the total. Among family clinicians in ND with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,533in general payments, 2019–2025

Across 66 payments — averaging $53.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kerecis Limited$1K
  • Smith+Nephew$700
  • AbbVie$340
  • Gilead$332
  • Insmed, Inc.$152
  • Melinta Therapeutics, LLC$125
  • plus $411 from 7 others

What the payments were for

  • Travel & lodging$1,21634%
  • Food & beverage$2,28365%
  • Education$331%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,533 in reported general payments places this provider in the 95th percentile of 496 family providers in North Dakota.

See all family providers in North Dakota

Medicare billing

Part B allowed, 2024
$20,624
Medicare patients
149
Services billed
306

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cefpodoxime Proxetil33$6,537
Methenamine Hippurate62$4,206
Vancomycin Hcl24$3,092
CeftriaxoneCeftriaxone Sodium11$2,337
Dicloxacillin Sodium21$2,295
Doxycycline Hyclate86$1,654
Linezolid26$1,202
Rifampin26$1,137
Ethambutol Hcl26$602
Fluconazole28$407
Cephalexin37$384
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav16$226
Levofloxacin17$214
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim24$182
Ciprofloxacin Hcl23$139

Paid to pharmacies, not to this prescriber.

Other family in Bismarck

See the full list for North Dakota

Where these figures come from

Is this you, or does something look wrong? →